WFC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WFC is not a good buy right now for an impatient buyer. Despite solid 2025/Q4 growth and generally rising Street price targets, the near-term setup skews bearish-to-rangebound (bearish options positioning, a recent Congress sale, MACD still below zero, and statistical pattern odds pointing to further downside over 1D/1W/1M). If you already own it, holding makes more sense than adding at ~$90.4 into nearby resistance.
Price/levels: WFC closed at 90.44, sitting just above R1 (90.347) with the next resistance at R2 (91.532). Support is lower at the pivot (88.429) then S1 (86.512). Trend/momentum: MACD histogram is negative (-0.116) but contracting (selling pressure easing, not reversed). RSI(6) ~59 is neutral-to-slightly bullish, not overbought. Converging moving averages suggest consolidation rather than a clean uptrend. Pattern/stat model: Similar-candlestick analysis indicates elevated downside risk (-2.65% next day, -5.42% next week, -8.86% next month probabilities/expectations), which argues against chasing price here.
Intellectia Proprietary Trading Signals
2025/Q4 fundamentals improved (revenue, net income, EPS up YoY), supporting the medium-term earnings narrative.
Analysts broadly raised price targets into 2026 outlook notes (multiple PT raises into the 100–113 range), reflecting expectations for NIM healing, capital return, and improved efficiency.
News item: CEO compensation increase framed as progress on resolving compliance issues—supports “execution improving” narrative.
Options positioning is bearish (P/C ratios > 1 on both OI and volume).
Latest quarter: 2025/Q4. Revenue 20.963B (+6.59% YoY), Net Income 5.114B (+6.52% YoY), EPS 1.62 (+13.29% YoY). This is a healthy growth profile with EPS outpacing revenue, consistent with operating leverage/efficiency improvements—fundamentals are supportive, but they’re not currently translating into a clean technical uptrend.
Recent trend: Price targets have been moving up across multiple firms (e.g., Barclays to 113, Evercore to 110, Wolfe to 109, Truist to 104, TD Cowen to 102), suggesting improving earnings/capital return expectations for 2026. Ratings are mixed: several Outperform/Overweight/Buy calls, but also notable caution (HSBC Hold; TD Cowen Hold; KBW Market Perform) and one downgrade (Baird to Underperform with PT 90). Wall Street pros: improving NIM/ROTCE outlook, capital returns/buybacks, efficiency gains, potential sector tailwinds in 2026. Wall Street cons: valuation/limited upside per the bearish downgrade, and sensitivity to loan demand/regulatory pressures.
